Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S1 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
  1. Home
  2. Publications
  3. Supplementary Figure S1 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality

Supplementary Figure S1 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality

Authors:
  • SHShernan G. Holtan
    Shernan G. Holtan
  • CSConstanza Savid-Frontera
    Constanza Savid-Frontera
  • KWKelly Walton
    Kelly Walton
  • AEAnne A. Eaton
    Anne A. Eaton
  • CDConnor Demorest
    Connor Demorest
  • AHAndrea Hoeschen
    Andrea Hoeschen
  • LZLing Zhang
    Ling Zhang
  • KRKayla Reid
    Kayla Reid
  • TKTony Kurian
    Tony Kurian
  • ZSZena Sayegh
    Zena Sayegh
  • EJEstefania Julia
    Estefania Julia
  • JMJoseph Maakaron
    Joseph Maakaron

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30707044
Abstract
Increased CD4 T cell CD83 expression is associated with earlier acute GVHD diagnosis
Keywords
  • BIOMARKERS
  • HEMATOLOGICAL CANCERS
  • LEUKEMIAS
  • IMMUNOLOGY
  • GRAFT VERSUS HOST DISEASE
  • IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.